Bellevue Group AG

Q1 2022 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
3/31/2022
Date filed
5/13/2022
Form type
13F-HR
Num holdings
177
Total value ($000)
$8,611,961
Net value change ($000)
-1,089,537 (-11.2%)
New positions
16
Sold out positions
30
Turnover %
2.9%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/10/2022 Next filing: 8/11/2022 SEC filing

Snapshot: Change Analysis

Compared to Q4 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OM 65,741 254.4%
IONS 52,259 16.6%
BSX 47,437 37.7%
AUPH 29,784 NEW
CSTL 27,258 NEW
APLS 25,065 81.5%
Axonics, Inc. 23,447 22.4%
ADY 19,938 25.1%
Intra-Cellular Therapies, Inc. 19,921 10.5%
Radius Health, Inc. 19,694 36.6%
Top Reduces (Value $000, Stocks/ETFs)
MRNA -151,720 -34.9%
BIIB -121,251 -96.3%
DHR -89,971 -46.2%
FATE -82,258 -37.2%
HUM -76,711 -54.5%
VOCERA COMMUNICATIONS, INC. -75,254 -100.0%
MGNX -72,858 -53.0%
ABT -53,614 -21.8%
ARGX -48,587 -13.9%
EPIX -40,380 -56.5%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type